FDA Document on GreenBio Nutrients Joint Health Capsules

The FDA has made a document available concerning GreenBio Nutrients Inc.'s products, ILEXPOWER and JointAlive Capsules, which are marketed for joint health and supporting a healthy inflammatory response. The document is listed under FDA-2025-S-0024-1954 on the Regs.gov platform. As no specific regulatory action, proposed rule, or enforcement is detailed, this appears to be an informational notice or filing.

Given the limited information and the absence of explicit regulatory requirements or deadlines, no immediate compliance actions are mandated for regulated entities. Companies marketing similar products should be aware that the FDA is monitoring such submissions. Further review of the full document, if available, would be necessary to ascertain any specific implications or claims made by the manufacturer.